Saint-Pierre-du-Mont, France

Lise H Pasquet

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lise H Pasquet: Innovator in Cancer Treatment

Introduction

Lise H Pasquet is a notable inventor based in Saint-Pierre-du-Mont, France. She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic compounds. Her work focuses on the activation of Type II NKT cells, which play a crucial role in the immune response against cancer.

Latest Patents

Lise H Pasquet holds a patent for "3-o-sulfo-galactosylceramide analogs as activators of type II NKT cells and uses thereof." This patent discloses compounds that are useful in the activation of Type II NKT cells, which can be instrumental in treating cancer. The compounds are described by specific formulas that enhance their effectiveness in medical applications.

Career Highlights

Throughout her career, Lise has worked with prominent organizations, including the Government of the United States of America as represented by the Secretary of the Department of Health and Human Services and the University of Connecticut. Her work in these institutions has allowed her to advance her research and contribute to significant medical advancements.

Collaborations

Lise has collaborated with esteemed colleagues such as Jay A Berzofsky and Amy R Howell. These partnerships have enriched her research and expanded the impact of her innovations in the medical field.

Conclusion

Lise H Pasquet is a pioneering inventor whose work in cancer treatment through the activation of Type II NKT cells has the potential to change the landscape of immunotherapy. Her contributions are invaluable to the ongoing fight against cancer, and her innovative spirit continues to inspire future research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…